Report Cover

Global Immuno-Oncology Market Growth (Status and Outlook) 2021-2026


According to this latest study, the 2021 growth of Immuno-Oncology will have significant change from previous year. By the most conservative estimates of global Immuno-Oncology market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 37120 million in 2020. Over the next five years the Immuno-Oncology market will register a 15.5% CAGR in terms of revenue, the global market size will reach US$ 65970 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-Oncology market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
    Immune Checkpoint Inhibitors
    Cytokine-Based Immunotherapy
    Cancer Vaccines
    CAR-T Cell Therapy
    Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
    Hospitals
    Drugstores
    Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    Bristol-Myers Squibb
    Merck & Co., Inc.
    Roche AG
    AstraZeneca, Plc
    Sanofi S.A.
    Dendreon Pharmaceuticals
    Novartis
    Gilead Sciences Inc.
    Merck KGaA
1 Scope of the Report
1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Immuno-Oncology Market Size 2016-2026
        2.1.2 Immuno-Oncology Market Size CAGR by Region 2020 VS 2021 VS 2026
    2.2 Immuno-Oncology Segment by Type
        2.2.1 Immune Checkpoint Inhibitors
        2.2.2 Immune Checkpoint Inhibitors
        2.2.3 Cancer Vaccines
        2.2.4 CAR-T Cell Therapy
        2.2.5 Others
    2.3 Immuno-Oncology Market Size by Type
        2.3.1 Global Immuno-Oncology Market Size CAGR by Type
        2.3.2 Global Immuno-Oncology Market Size Market Share by Type (2016-2021)
    2.4 Immuno-Oncology Segment by Application
        2.4.1 Hospitals
        2.4.2 Drugstores
        2.4.3 Others
    2.5 Immuno-Oncology Market Size by Application
        2.5.1 Global Immuno-Oncology Market Size CAGR by Application
        2.5.2 Global Immuno-Oncology Market Size Market Share by Application (2016-2021)

3 Immuno-Oncology Market Size by Players
    3.1 Immuno-Oncology Market Size Market Share by Players
        3.1.1 Global Immuno-Oncology Revenue by Players (2019-2021E)
        3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2019-2021E)
    3.2 Global Immuno-Oncology Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Immuno-Oncology by Regions
    4.1 Immuno-Oncology Market Size by Regions (2016-2021)
    4.2 Americas Immuno-Oncology Market Size Growth (2016-2021)
    4.3 APAC Immuno-Oncology Market Size Growth (2016-2021)
    4.4 Europe Immuno-Oncology Market Size Growth (2016-2021)
    4.5 Middle East & Africa Immuno-Oncology Market Size Growth (2016-2021)

5 Americas
    5.1 Americas Immuno-Oncology Market Size by Country (2016-2021)
    5.2 Americas Immuno-Oncology Market Size by Type (2016-2021)
    5.3 Americas Immuno-Oncology Market Size by Application (2016-2021)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Immuno-Oncology Market Size by Region (2016-2021)
    6.2 APAC Immuno-Oncology Market Size by Type (2016-2021)
    6.3 APAC Immuno-Oncology Market Size by Application (2016-2021)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Immuno-Oncology by Country (2016-2021)
    7.2 Europe Immuno-Oncology Market Size by Type (2016-2021)
    7.3 Europe Immuno-Oncology Market Size by Application (2016-2021)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Immuno-Oncology by Region (2016-2021)
    8.2 Middle East & Africa Immuno-Oncology Market Size by Type (2016-2021)
    8.3 Middle East & Africa Immuno-Oncology Market Size by Application (2016-2021)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Global Immuno-Oncology Market Forecast
    10.1 Global Immuno-Oncology Forecast by Regions (2021-2026)
        10.1.1 Global Immuno-Oncology Forecast by Regions (2021-2026)
        10.1.2 Americas Immuno-Oncology Forecast
        10.1.3 APAC Immuno-Oncology Forecast
        10.1.4 Europe Immuno-Oncology Forecast
        10.1.5 Middle East & Africa Immuno-Oncology Forecast
    10.2 Americas Immuno-Oncology Forecast by Countries (2021-2026)
        10.2.1 United States Immuno-Oncology Market Forecast
        10.2.2 Canada Immuno-Oncology Market Forecast
        10.2.3 Mexico Immuno-Oncology Market Forecast
        10.2.4 Brazil Immuno-Oncology Market Forecast
    10.3 APAC Immuno-Oncology Forecast by Region (2021-2026)
        10.3.1 China Immuno-Oncology Market Forecast
        10.3.2 Japan Immuno-Oncology Market Forecast
        10.3.3 Korea Immuno-Oncology Market Forecast
        10.3.4 Southeast Asia Immuno-Oncology Market Forecast
        10.3.5 India Immuno-Oncology Market Forecast
        10.3.6 Australia Immuno-Oncology Market Forecast
    10.4 Europe Immuno-Oncology Forecast by Country (2021-2026)
        10.4.1 Germany Immuno-Oncology Market Forecast
        10.4.2 France Immuno-Oncology Market Forecast
        10.4.3 UK Immuno-Oncology Market Forecast
        10.4.4 Italy Immuno-Oncology Market Forecast
        10.4.5 Russia Immuno-Oncology Market Forecast
    10.5 Middle East & Africa Immuno-Oncology Forecast by Region (2021-2026)
        10.5.1 Egypt Immuno-Oncology Market Forecast
        10.5.2 South Africa Immuno-Oncology Market Forecast
        10.5.3 Israel Immuno-Oncology Market Forecast
        10.5.4 Turkey Immuno-Oncology Market Forecast
        10.5.5 GCC Countries Immuno-Oncology Market Forecast
    10.6 Global Immuno-Oncology Forecast by Type (2021-2026)
    10.8 Global Immuno-Oncology Forecast by Application (2021-2026)

11 Key Players Analysis
    11.1 Bristol-Myers Squibb
        11.1.1 Bristol-Myers Squibb Company Information
        11.1.2 Bristol-Myers Squibb Immuno-Oncology Product Offered
        11.1.3 Bristol-Myers Squibb Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
        11.1.4 Bristol-Myers Squibb Main Business Overview
        11.1.5 Bristol-Myers Squibb Latest Developments
    11.2 Merck & Co., Inc.
        11.2.1 Merck & Co., Inc. Company Information
        11.2.2 Merck & Co., Inc. Immuno-Oncology Product Offered
        11.2.3 Merck & Co., Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
        11.2.4 Merck & Co., Inc. Main Business Overview
        11.2.5 Merck & Co., Inc. Latest Developments
    11.3 Roche AG
        11.3.1 Roche AG Company Information
        11.3.2 Roche AG Immuno-Oncology Product Offered
        11.3.3 Roche AG Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
        11.3.4 Roche AG Main Business Overview
        11.3.5 Roche AG Latest Developments
    11.4 AstraZeneca, Plc
        11.4.1 AstraZeneca, Plc Company Information
        11.4.2 AstraZeneca, Plc Immuno-Oncology Product Offered
        11.4.3 AstraZeneca, Plc Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
        11.4.4 AstraZeneca, Plc Main Business Overview
        11.4.5 AstraZeneca, Plc Latest Developments
    11.5 Sanofi S.A.
        11.5.1 Sanofi S.A. Company Information
        11.5.2 Sanofi S.A. Immuno-Oncology Product Offered
        11.5.3 Sanofi S.A. Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
        11.5.4 Sanofi S.A. Main Business Overview
        11.5.5 Sanofi S.A. Latest Developments
    11.6 Dendreon Pharmaceuticals
        11.6.1 Dendreon Pharmaceuticals Company Information
        11.6.2 Dendreon Pharmaceuticals Immuno-Oncology Product Offered
        11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
        11.6.4 Dendreon Pharmaceuticals Main Business Overview
        11.6.5 Dendreon Pharmaceuticals Latest Developments
    11.7 Novartis
        11.7.1 Novartis Company Information
        11.7.2 Novartis Immuno-Oncology Product Offered
        11.7.3 Novartis Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
        11.7.4 Novartis Main Business Overview
        11.7.5 Novartis Latest Developments
    11.8 Gilead Sciences Inc.
        11.8.1 Gilead Sciences Inc. Company Information
        11.8.2 Gilead Sciences Inc. Immuno-Oncology Product Offered
        11.8.3 Gilead Sciences Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
        11.8.4 Gilead Sciences Inc. Main Business Overview
        11.8.5 Gilead Sciences Inc. Latest Developments
    11.9 Merck KGaA
        11.9.1 Merck KGaA Company Information
        11.9.2 Merck KGaA Immuno-Oncology Product Offered
        11.9.3 Merck KGaA Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
        11.9.4 Merck KGaA Main Business Overview
        11.9.5 Merck KGaA Latest Developments

12 Research Findings and Conclusion

List of Tables Table 1. Immuno-Oncology Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Immune Checkpoint Inhibitors Table 3. Major Players of Cytokine-Based Immunotherapy Table 4. Major Players of Cancer Vaccines Table 5. Major Players of CAR-T Cell Therapy Table 6. Major Players of Others Table 7. Immuno-Oncology Market Size CAGR by Type (2020-2026) & ($ Millions) Table 8. Global Immuno-Oncology Market Size by Type (2016-2021) & ($ Millions) Table 9. Global Immuno-Oncology Market Size Market Share by Type (2016-2021) Table 10. Immuno-Oncology Market Size CAGR by Application (2016-2021) & ($ Millions) Table 11. Global Immuno-Oncology Market Size by Application (2016-2021) & ($ Millions) Table 12. Global Immuno-Oncology Market Size Market Share by Application (2016-2021) Table 13. Global Immuno-Oncology Revenue by Players (2019-2021E) & ($ Millions) Table 14. Global Immuno-Oncology Revenue Market Share by Players (2019-2021E) Table 15. Immuno-Oncology Key Players Head office and Products Offered Table 16. Immuno-Oncology Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Immuno-Oncology Market Size by Regions 2016-2021 & ($ Millions) Table 20. Global Immuno-Oncology Market Size Market Share by Regions 2016-2021 Table 21. Americas Immuno-Oncology Market Size by Country (2016-2021) & ($ Millions) Table 22. Americas Immuno-Oncology Market Size Market Share by Country (2016-2021) Table 23. Americas Immuno-Oncology Market Size by Type (2016-2021) & ($ Millions) Table 24. Americas Immuno-Oncology Market Size Market Share by Type (2016-2021) Table 25. Americas Immuno-Oncology Market Size by Application (2016-2021) & ($ Millions) Table 26. Americas Immuno-Oncology Market Size Market Share by Application (2016-2021) Table 27. APAC Immuno-Oncology Market Size by Region (2016-2021) & ($ Millions) Table 28. APAC Immuno-Oncology Market Size Market Share by Region (2016-2021) Table 29. APAC Immuno-Oncology Market Size by Type (2016-2021) & ($ Millions) Table 30. APAC Immuno-Oncology Market Size Market Share by Type (2016-2021) Table 31. APAC Immuno-Oncology Market Size by Application (2016-2021) & ($ Millions) Table 32. APAC Immuno-Oncology Market Size Market Share by Application (2016-2021) Table 33. Europe Immuno-Oncology Market Size by Country (2016-2021) & ($ Millions) Table 34. Europe Immuno-Oncology Market Size Market Share by Country (2016-2021) Table 35. Europe Immuno-Oncology Market Size by Type (2016-2021) & ($ Millions) Table 36. Europe Immuno-Oncology Market Size Market Share by Type (2016-2021) Table 37. Europe Immuno-Oncology Market Size by Application (2016-2021) & ($ Millions) Table 38. Europe Immuno-Oncology Market Size Market Share by Application (2016-2021) Table 39. Middle East & Africa Immuno-Oncology Market Size by Region (2016-2021) & ($ Millions) Table 40. Middle East & Africa Immuno-Oncology Market Size Market Share by Region (2016-2021) Table 41. Middle East & Africa Immuno-Oncology Market Size by Type (2016-2021) & ($ Millions) Table 42. Middle East & Africa Immuno-Oncology Market Size Market Share by Type (2016-2021) Table 43. Middle East & Africa Immuno-Oncology Market Size by Application (2016-2021) & ($ Millions) Table 44. Middle East & Africa Immuno-Oncology Market Size Market Share by Application (2016-2021) Table 45. Key and Potential Regions of Immuno-Oncology Table 46. Key Application and Potential Industries of Immuno-Oncology Table 47. Key Challenges of Immuno-Oncology Table 48. Key Trends of Immuno-Oncology Table 49. Global Immuno-Oncology Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 50. Global Immuno-Oncology Market Size Market Share Forecast by Regions (2021-2026) Table 51. Global Immuno-Oncology Market Size Forecast by Type (2021-2026) & ($ Millions) Table 52. Global Immuno-Oncology Market Size Market Share Forecast by Type (2021-2026) Table 53. Global Immuno-Oncology Market Size Forecast by Application (2021-2026) & ($ Millions) Table 54. Global Immuno-Oncology Market Size Market Share Forecast by Application (2021-2026) Table 55. Bristol-Myers Squibb Details, Company Type, Immuno-Oncology Area Served and Its Competitors Table 56. Bristol-Myers Squibb Immuno-Oncology Product Offered Table 57. Bristol-Myers Squibb Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 58. Bristol-Myers Squibb Main Business Table 59. Bristol-Myers Squibb Latest Developments Table 60. Merck & Co., Inc. Details, Company Type, Immuno-Oncology Area Served and Its Competitors Table 61. Merck & Co., Inc. Immuno-Oncology Product Offered Table 62. Merck & Co., Inc. Main Business Table 63. Merck & Co., Inc. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 64. Merck & Co., Inc. Latest Developments Table 65. Roche AG Details, Company Type, Immuno-Oncology Area Served and Its Competitors Table 66. Roche AG Immuno-Oncology Product Offered Table 67. Roche AG Main Business Table 68. Roche AG Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 69. Roche AG Latest Developments Table 70. AstraZeneca, Plc Details, Company Type, Immuno-Oncology Area Served and Its Competitors Table 71. AstraZeneca, Plc Immuno-Oncology Product Offered Table 72. AstraZeneca, Plc Main Business Table 73. AstraZeneca, Plc Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 74. AstraZeneca, Plc Latest Developments Table 75. Sanofi S.A. Details, Company Type, Immuno-Oncology Area Served and Its Competitors Table 76. Sanofi S.A. Immuno-Oncology Product Offered Table 77. Sanofi S.A. Main Business Table 78. Sanofi S.A. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 79. Sanofi S.A. Latest Developments Table 80. Dendreon Pharmaceuticals Details, Company Type, Immuno-Oncology Area Served and Its Competitors Table 81. Dendreon Pharmaceuticals Immuno-Oncology Product Offered Table 82. Dendreon Pharmaceuticals Main Business Table 83. Dendreon Pharmaceuticals Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 84. Dendreon Pharmaceuticals Latest Developments Table 85. Novartis Details, Company Type, Immuno-Oncology Area Served and Its Competitors Table 86. Novartis Immuno-Oncology Product Offered Table 87. Novartis Main Business Table 88. Novartis Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 89. Novartis Latest Developments Table 90. Gilead Sciences Inc. Details, Company Type, Immuno-Oncology Area Served and Its Competitors Table 91. Gilead Sciences Inc. Immuno-Oncology Product Offered Table 92. Gilead Sciences Inc. Main Business Table 93. Gilead Sciences Inc. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 94. Gilead Sciences Inc. Latest Developments Table 95. Merck KGaA Details, Company Type, Immuno-Oncology Area Served and Its Competitors Table 96. Merck KGaA Immuno-Oncology Product Offered Table 97. Merck KGaA Main Business Table 98. Merck KGaA Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 99. Merck KGaA Latest Developments List of Figures Figure 1. Immuno-Oncology Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Immuno-Oncology Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Immuno-Oncology Market Size Market Share by Type in 2020 Figure 7. Immuno-Oncology in Hospitals Figure 8. Global Immuno-Oncology Market: Hospitals (2016-2021) & ($ Millions) Figure 9. Immuno-Oncology in Drugstores Figure 10. Global Immuno-Oncology Market: Drugstores (2016-2021) & ($ Millions) Figure 11. Immuno-Oncology in Others Figure 12. Global Immuno-Oncology Market: Others (2016-2021) & ($ Millions) Figure 13. Global Immuno-Oncology Market Size Market Share by Application in 2020 Figure 14. Global Immuno-Oncology Revenue Market Share by Player in 2020 Figure 15. Global Immuno-Oncology Market Size Market Share by Regions (2016-2021) Figure 16. Americas Immuno-Oncology Market Size 2016-2021 ($ Millions) Figure 17. APAC Immuno-Oncology Market Size 2016-2021 ($ Millions) Figure 18. Europe Immuno-Oncology Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Immuno-Oncology Market Size 2016-2021 ($ Millions) Figure 20. Americas Immuno-Oncology Market Size Market Share by Country in 2020 Figure 21. Americas Immuno-Oncology Market Size Market Share by Type in 2020 Figure 22. Americas Immuno-Oncology Market Size Market Share by Application in 2020 Figure 23. United States Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Immuno-Oncology Market Size Market Share by Regions in 2020 Figure 27. APAC Immuno-Oncology Market Size Market Share by Type in 2020 Figure 28. APAC Immuno-Oncology Market Size Market Share by Application in 2020 Figure 29. China Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 33. India Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Immuno-Oncology Market Size Market Share by Country in 2020 Figure 36. Europe Immuno-Oncology Market Size Market Share by Type in 2020 Figure 37. Europe Immuno-Oncology Market Size Market Share by Application in 2020 Figure 38. Germany Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 39. France Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Immuno-Oncology Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Immuno-Oncology Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Immuno-Oncology Market Size Market Share by Application in 2020 Figure 46. Egypt Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Immuno-Oncology Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 52. APAC Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 53. Europe Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 55. United States Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 56. Canada Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 57. Mexico Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 58. Brazil Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 59. China Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 60. Japan Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 61. Korea Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 63. India Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 64. Australia Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 65. Germany Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 66. France Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 67. UK Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 68. Italy Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 69. Russia Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 70. Spain Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 71. Egypt Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 72. South Africa Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 73. Israel Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 74. Turkey Immuno-Oncology Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Immuno-Oncology Market Size 2021-2026 ($ Millions)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: LP Information Inc
Chat with us